GPT and hepatocellular carcinoma: Adjusted HRs of HCC in patients with ALT levels of 40–80, 80–120, and > 120 U/L were 3.85 (95% CI 3.34–4.45), 7.05 (5.70–8.71), and 10.85 (8.81–13.36), respectively, after multivariate adjustment (P for trend: <0.001), compared with persons exhibiting ALT levels ≤ 40 U/L.